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ABSTRACT
Background The ageing population and prevalence of 
long- term disorders with multimorbidity are a major health 
challenge worldwide. The associations between comorbid 
conditions and mortality risk are well established; 
however, few prospective community- based studies 
have reported on prior risk factors for incident hospital 
admissions with multimorbidity. We aimed to explore the 
independent associations for a range of demographic, 
lifestyle and physiological determinants and the likelihood 
of subsequent hospital incident multimorbidity.
Methods We examined incident hospital admissions with 
multimorbidity in 25 014 men and women aged 40–79 in 
a British prospective population- based study recruited in 
1993–1997 and followed up until 2019. The determinants 
of incident multimorbidity, defined as Charlson Comorbidity 
Index ≥3, were investigated using multivariable logistic 
regression models for the 10- year period 1999–2009 and 
repeated with independent measurements in a second 
10- year period 2009–2019.
Results Between 1999 and 2009, 18 179 participants 
(73% of the population) had a hospital admission. Baseline 
5- year and 10- year incident multimorbidities were 
observed in 6% and 12% of participants, respectively. 
Age per 10- year increase (OR 2.19, 95% CI 2.06 to 2.33) 
and male sex (OR 1.32, 95% CI 1.19 to 1.47) predicted 
incident multimorbidity over 10 years. In the subset free 
of the most serious diseases at baseline, current smoking 
(OR 1.86, 95% CI 1.60 to 2.15), body mass index >30 kg/
m² (OR 1.48, 95% CI 1.30 to 1.70) and physical inactivity 
(OR 1.16, 95% CI 1.04 to 1.29) were positively associated 
and plasma vitamin C (a biomarker of plant food intake) 
per SD increase (OR 0.86, 95% CI 0.81 to 0.91) inversely 
associated with incident 10- year multimorbidity after 
multivariable adjustment for age, sex, social class, 
education, alcohol consumption, systolic blood pressure 
and cholesterol. Results were similar when re- examined 
for a further time period in 2009–2019.
Conclusion Age, male sex and potentially modifiable 
lifestyle behaviours including smoking, body mass index, 
physical inactivity and low fruit and vegetable intake were 
associated with increased risk of future incident hospital 
admissions with multimorbidity.
INTRODUCTION
The Academy of Medical Sciences 2018 
report highlighted multimorbidity as a global 
priority for research. Patients with multimor-
bidity experience reduced well- being and 
quality of life and account for a dispropor-
tionately high share of healthcare workload 
and costs. Management of the rising preva-
lence of long- term disorders is the main chal-
lenge facing healthcare systems worldwide.1–3
Multimorbidity is commonly defined as the 
presence of multiple diseases or conditions 
with a cut- off of two or more conditions4; 
however, there is no agreed definition or clas-
sification system, which makes the existing 
evidence base difficult to interpret.1 The 
term comorbidity predates multimorbidity 
and was used to predict the effect of addi-
tional diseases for those with an index disease 
of interest.5–7 The Charlson Comorbidity 
Index (CCI)8 was originally created to predict 
mortality in hospital patients after 1 year and 
is defined using a set of 17 chronic diseases, 
Strengths and limitations of this study
 ► We examined future hospital admission with mul-
timorbidity using a prospective design and a 
community- based population.
 ► The relationship between demographic, lifestyle and 
physiological factors and subsequent multimorbidity 
was documented.
 ► Measurements were made at two time- points: in 
mainly middle- aged participants (40–79 years) and 
mainly old- aged participants (48–92 years).
 ► Participants were followed over 20 years, allowing 
several time periods to be examined.
 ► Restricting the definition of multimorbidity to a sub-
set of chronic conditions means some conditions 
will not be counted.
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weighted according to the risk of death. The index has 
been widely used, with several authors suggesting exten-
sions or modifications to the original definition,9–14 and it 
remains a common standard with which other systems are 
often compared.15
The associations between comorbid conditions and 
mortality are well established.16–20 However, few studies 
have examined the determinants of incident multimor-
bidity rather than its consequences,21–26 since most lack 
detailed demographic, socioeconomic and physiological 
measurements in population- based men and women 
prior to the onset of multimorbid disease with subsequent 
follow- up. Retrospective hospital- based studies examining 
multimorbidity lack community- based denominators, 
while general practice- based studies are often cross- 
sectional or examine mortality in already multimorbid 
patients. Few studies examine factors that predict the like-
lihood of multimorbidity rather than factors that predict 
risk of individual component conditions. The large 
majority of studies conducted to date are cross- sectional, 
with few prospective community- based studies able to 
examine incident multimorbidity from subsequent hospi-
talisation.1 24 25 In this study, we examine the independent 
associations for a range of demographic, lifestyle and 
physiological determinants and the likelihood of subse-
quent hospital incident multimorbidity. We use the CCI 
over 5- year and 10- year time periods and re- examine 
these associations independently in a subset 12 years after 
baseline since healthcare policy and the criteria used for 
admission may have changed over time. We have previ-
ously reported on risk factors for hospitalisation,27–29 but 
here we explore in more detail hospital admissions with 
multimorbidity, a measure of both health service and 
individual burden.
METHODS
We used data from the European Prospective Investiga-
tion into Cancer in Norfolk cohort (EPIC- Norfolk).30 31 
From this cohort, 25 639 men and women aged 40–79 were 
recruited from general practices in Norfolk, completed 
a lifestyle questionnaire and attended a baseline health 
check from 1993 to 1997. Participants were reapproached 
approximately 12 years later, aged 48–92, with 9814 
completing a second questionnaire and 8049 attending a 
health check at time- point 2 (TP2). Figure 1 shows a flow 
diagram of the number of participants at various stages. 
The cohort was followed until 2019 with annual record 
linkage to hospital episode data. Since linkage was to 
national databases and migration of cohort participants 
was rare, there was almost no loss to follow- up.
The CCI is defined using a set of chronic diseases, each 
having an associated weight (1, 2, 3 or 6) related to the 
risk of death. The conditions are myocardial infarction, 
congestive heart failure, peripheral vascular disease, 
cerebrovascular disease, dementia, chronic pulmonary 
disease, rheumatoid disease, peptic ulcer disease, liver 
disease, diabetes, hemiplegia or paraplegia, renal disease, 
cancer and AIDS/HIV. Two levels of severity are defined 
for liver disease, diabetes and cancer (details are shown 
in online supplemental table S1). All comorbidities are 
assigned a weight of 1, except hemiplegia/paraplegia, 
Figure 1 Flow diagram of cohort recruitment and 
approaches.
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renal disease and malignancies (weight=2); moderate/
severe liver disease (weight=3); and metastatic solid 
tumour and AIDS/HIV (weight=6). For diseases with 
two levels of severity (liver disease, diabetes and cancer), 
the less severe version is assigned a weight of 0 if the 
more severe version is also present in a patient. The CCI 
diseases were assigned diagnosis codes using the Interna-
tional Classification of Diseases (ICD-10), which was used 
to link the CCI to Hospital Episode Statistics records and 
to cohort participants. The weighted individual disease 
scores were totalled to create an overall score with a 
maximum value of 29.8 12 CCI was measured for various 
outcome periods restricted to all hospital events within 
the given time period: at baseline, 5- year (1999–2004) 
and 10- year (1999–2009) CCI; and at TP2, 5- year (2009–
2014) and 10- year (2009–2019) CCI. Multiple admissions 
including the same CCI category were only counted once.
Participants attending the baseline and TP2 health exam-
inations had their height to the nearest 0.1 cm measured 
using a stadiometer (Chasemores, UK) and their weight to 
the nearest 100 g measured in light clothing without shoes 
(Salter, West Bromwich, UK). Body mass index (BMI) was 
calculated using measured weight in kilograms divided by 
the square of measured height in square metres. Trained 
nurses obtained non- fasting blood samples by venepunc-
ture into plain and citrate bottles. Bloods were assayed 
at the Department of Clinical Biochemistry, University of 
Cambridge, UK. Serum concentrations of total choles-
terol were measured with the RA-1000 Technicon analyser 
(Bayer Diagnostics, Basingstoke). Plasma was stabilised 
in a standardised volume of metaphosphoric acid stored 
at −70°C and vitamin C concentrations measured using 
a fluorometric assay within 1 week.32 Systolic blood pres-
sure was measured using an Accutorr sphygmomanom-
eter (Datascope Medical, Huntington, UK). Participants 
sat for 3 min before two measurements were taken with 
the arm horizontal and held at mid- sternum level. Systolic 
blood pressure was defined as the average of the two 
measurements.
At baseline and again at TP2, participants completed a 
lifestyle questionnaire. Two yes/no questions were used 
to derive smoking status: ‘Have you ever smoked as much 
as one cigarette a day for as long as a year?’ and, where 
a positive response was given, ‘Do you smoke cigarettes 
now?’ Participants also completed questions about their 
employment and that of their partner, with details of both 
current and past employment recorded. Occupational 
social class was defined according to the Registrar Gener-
al’s classification.33 34 A list of common UK qualifications 
was used to establish educational attainment and partic-
ipants were asked to mark all relevant qualifications. 
These were then categorised using the highest qualifica-
tion attained. Participants were asked about their occupa-
tional and leisure physical activity. A combined score was 
created combining leisure and occupational elements 
and divided into four ordered categories, with those who 
did not complete the question placed in the inactive cate-
gory. The score was validated against energy expenditure 
measured by free- living heart rate monitoring with indi-
vidual calibration.35 36 Participants were asked ‘Are you 
a non- drinker/teetotaller now?’ and ‘At present, about 
how many alcoholic drinks do you have each week’ for 
various types of alcohol. Current units were calculated 
from the questionnaire responses, with one unit equal to 
a half pint of beer, one glass of wine or fortified wine or 
a single measure of spirits. Prevalent disease was estab-
lished from the question ‘Has the doctor ever told you 
that you have any of the following?’ followed by a list of 
common conditions including ‘Heart attack (myocardial 
infarction)’, ‘Stroke’, ‘Cancer’ and ‘Diabetes’.
Statistical methods
Associations were examined both including and excluding 
chronic disease at baseline and repeated with indepen-
dent measurements at TP2 in a subset of participants 
using a second baseline 12 years approximately after the 
first. The baseline analysis excludes 625 men and women 
who died before 1999, while at TP2 a further 126 partic-
ipants who died prior to 2009 were excluded. Dichoto-
mous variables were created for social class (manual and 
non- manual), educational attainment (high and low) 
at baseline, and BMI (>30 kg/m² and ≤30 kg/m²) and 
usual physical activity (active and inactive) at both base-
line and TP2. For social class, professional, managerial 
and technical and non- manual skilled occupations were 
classed as non- manual, while manual skilled, partly skilled 
and unskilled were classed as manual. For educational 
attainment, those with qualifications at secondary level 
or above were classed as high and those with no quali-
fication as low. Hospital outcomes were categorised into 
five groups: ‘No hospital admissions’, CCI=0, CCI=1, 
CCI=2 and hospital admissions with multimorbidity (inci-
dent multimorbidity) defined as CCI ≥3. Multivariable 
logistic regression was used for all models and compared 
multimorbid participants (CCI ≥3) with those having CCI 
≤2 or no hospital admissions. A sensitivity analysis, using 
identical models to those in the primary analyses for the 
period 1999–2009, but excluding 80 participants defined 
as multimorbid having only one condition with a CCI 
weighting ≥3, gave virtually identical results (results not 
shown).
The numbers of individuals with missing values for 
covariables at baseline were 53 for BMI, 218 for smoking 
status, 545 for social class and 18 for education level. 
The physical activity score has no missing values since 
those with missing data were classified as being inactive. 
Multiple imputation was used to estimate missing values 
at TP2 most apparent when participants completed 
questionnaires but did not attend a health examination 
(n=1891). Predictive mean matching with 5 multiple 
imputations and 50 iterations was used with baseline and 
TP2 variables. All analyses were performed using the R 
statistical language (V3.5.3, R Foundation for Statistical 
Computing, Vienna, Austria, with packages knitr, Gmisc, 
ggplot2, tidyverse, intubate, mice). CCIs were calculated 
using the R package ‘comorbidity’.37
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RESULTS
Table 1 shows future 5- year and 10- year CCI hospital 
admission rates from baseline for 25 014 and from TP2 
for 9814, according to demographic characteristics in the 
study population. Between 1999 and 2009, 18 179 partici-
pants (73% of the population) had a hospital admission. 
Baseline 5- year and 10- year incident multimorbidities 
(CCI ≥3) were observed in 6% and 12% of participants, 
respectively. Figure 2 shows the 10- year multimorbidity 
rates by age group and sex excluding those with cardio-
vascular disease, cancer or diabetes at baseline. More 
men had CCI ≥3 than women and those aged >75 years 
had the highest proportion of admissions with multi-
morbid conditions, with 14.5% at 5 years and 28.8% at 
10 years. Multimorbidity rates at TP2 were slightly higher 
than baseline, with 5- year and 10- year incident CCI ≥3 
observed in 10% and 20% of participants, respectively, 
and the highest proportion in those >75 years.
Descriptive characteristics of the cohort according 
to 10- year CCI are shown in table 2. Participants with 
higher number of total admissions and longer duration 
of hospital stay had higher CCI, with mean duration of 
58 days and 13 admissions for participants with CCI ≥3 
during the 10- year period. Participants with multimor-
bidity admissions were more likely at baseline examina-
tion to be current smokers, less physically active, have 
higher BMI and have lower plasma vitamin C (a proxy 
for a diet rich in fruit and vegetables) and report various 
prevalent conditions.
In table 3, ORs are shown for 5- year and 10- year inci-
dent multimorbidity, defined as those with CCI ≥3, 
compared with CCI ≤2 or no hospital admission, adjusted 
for age, sex, occupational social class and educational 
attainment in model 1. Model 2 additionally adjusted for 
prevalent diseases, cardiovascular disease (CVD), cancer 
and diabetes; model 3 added lifestyle factors, current 
Table 1 Charlson Comorbidity Index (CCI) hospital admission rates by age group and sex in men and women aged 40–79, 
1999–2019
Total No admissions CCI=0 CCI=1 CCI=2 CCI ≥3
Baseline 5- year follow- up period, 1999–2004, n (%)
  Men 11 228 5457 (48.6) 3340 (29.7) 988 (8.8) 662 (5.9) 781 (7.0)
  Women 13 786 7153 (51.9) 4398 (31.9) 953 (6.9) 643 (4.7) 639 (4.6)
  ≤55 years 9567 6009 (62.8) 2720 (28.4) 411 (4.3) 236 (2.5) 191 (2.0)
  55–65 years 7805 3940 (50.5) 2479 (31.8) 583 (7.5) 408 (5.2) 395 (5.1)
  65–75 years 6933 2489 (35.9) 2322 (33.5) 830 (12.0) 561 (8.1) 731 (10.5)
  >75 years 709 172 (24.3) 217 (30.6) 117 (16.5) 100 (14.1) 103 (14.5)
Baseline 10- year follow- up period, 1999–2009, n (%)
  Men 11 228 2928 (26.1) 4151 (37.0) 1434 (12.8) 1056 (9.4) 1659 (14.8)
  Women 13 786 3907 (28.3) 5767 (41.8) 1601 (11.6) 1137 (8.2) 1374 (10.0)
  ≤55 years 9567 3720 (38.9) 4201 (43.9) 746 (7.8) 476 (5.0) 424 (4.4)
  55–65 years 7805 1973 (25.3) 3259 (41.8) 994 (12.7) 711 (9.1) 868 (11.1)
  65–75 years 6933 1059 (15.3) 2294 (33.1) 1168 (16.8) 875 (12.6) 1537 (22.2)
  >75 years 709 83 (11.7) 164 (23.1) 127 (17.9) 131 (18.5) 204 (28.8)
Time- point 2, 5- year follow- up period, 2009–2014, n (%)
  Men 4252 1428 (33.6) 1355 (31.9) 522 (12.3) 389 (9.1) 558 (13.1)
  Women 5562 2234 (40.2) 1793 (32.2) 686 (12.3) 403 (7.2) 446 (8.0)
  ≤55 years 342 215 (62.9) 92 (26.9) 19 (5.6) 10 (2.9) 6 (1.8)
  55–65 years 3090 1540 (49.8) 1006 (32.6) 277 (9.0) 143 (4.6) 124 (4.0)
  65–75 years 3695 1303 (35.3) 1301 (35.2) 464 (12.6) 286 (7.7) 341 (9.2)
  >75 years 2687 604 (22.5) 749 (27.9) 448 (16.7) 353 (13.1) 533 (19.8)
Time- point 2, 10- year follow- up period, 2009–2019, n (%)
  Men 4252 695 (16.3) 1294 (30.4) 631 (14.8) 558 (13.1) 1074 (25.3)
  Women 5562 1166 (21.0) 1956 (35.2) 914 (16.4) 618 (11.1) 908 (16.3)
  ≤55 years 342 154 (45.0) 122 (35.7) 37 (10.8) 14 (4.1) 15 (4.4)
  55–65 years 3090 905 (29.3) 1241 (40.2) 407 (13.2) 267 (8.6) 270 (8.7)
  65–75 years 3695 589 (15.9) 1309 (35.4) 611 (16.5) 473 (12.8) 713 (19.3)
  >75 years 2687 213 (7.9) 578 (21.5) 490 (18.2) 422 (15.7) 984 (36.6)
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smoking, alcohol units per week, usual physical activity 
as well as BMI >30 kg/m² and plasma vitamin C; and 
model 4 added systolic blood pressure and cholesterol. 
Age, sex and prevalent diseases were strongly associated 
with multimorbidity admissions in all models. The fully 
adjusted association of 10- year incident multimorbidity 
with age per 10- year increase had OR of 2.19 (95% CI 
2.06 to 2.33), OR of 1.32 (95% CI 1.19 to 1.47) for sex, 
OR of 2.22 (95% CI 1.87 to 2.62) for prevalent CVD, OR 
of 2.05 (95% CI 1.73 to 2.42) for cancer, and OR of 3.41 
(95% CI 2.74 to 4.24) for diabetes. The risk of multimor-
bidity in participants with CVD at baseline was equivalent 
to the risk in those without CVD 10 years older. Similarly, 
in participants with baseline diabetes and baseline cancer, 
the risk was equivalent to those without disease aged 17 
and 11 years older, respectively.
The models in table 4 are similar to those used in 
table 3, but rather than adjusting for prevalent disease, 
participants who reported heart attack, stroke, cancer or 
diabetes at baseline were excluded. In this subgroup of 
participants without known common major diseases, in 
addition to age and sex, current cigarette smoking (OR 
1.86, 95% CI 1.60 to 2.15), BMI >30 kg/m² (OR 1.48, 95% 
CI 1.30 to 1.70) and physical inactivity (OR 1.16, 95% CI 
1.04 to 1.29) were positively associated and plasma vitamin 
C (OR 0.86, 95% CI 0.81 to 0.91) inversely associated with 
incident 10- year hospital admissions with multimorbidity 
after multivariable adjustment for age, sex, social class, 
education, alcohol consumption, systolic blood pressure 
and cholesterol (model 3). Manual social class and educa-
tional attainment were associated with incident multimor-
bidity in model 1, but were attenuated in models 2 and 3. 
An inverse association was observed for total cholesterol, 
while systolic blood pressure appeared to be associated 
but the direction of association was not consistent with 
the repeated analyses from TP2. There was no association 
for alcohol in these models. The risk of multimorbidity 
in current cigarette smokers is equivalent to the risk in 
non- smokers 7 years older, while each 20 µmol/L rise in 
plasma vitamin C (approximately two servings of fruit and 
vegetables per day38) corresponds to a reduction in risk 
equivalent to the risk of those 3 years younger.
Online supplemental table S1 shows the ICD-10 codes 
corresponding to CCI disease groups. Online supple-
mental table S2 shows the descriptive characteristics of 
participants at TP2 for 10- year CCI. The mean age in this 
subset, measured approximately 12 years after baseline, 
was 69.4. The number of hospital admissions and total 
length of stay were similar to those at baseline, with multi-
morbid participants (CCI ≥3) having much longer dura-
tion than non- multimorbid participants or those who had 
no hospital admissions. Multimorbid participants were 
inactive, had lower plasma vitamin C (reflecting a lower 
intake of fruit and vegetables), were current or former 
smokers, and had prevalent disease. In online supple-
mental table S3, multivariable models of 10- year incident 
multimorbidity show that prevalent diabetes, CVD and 
cancer were all strongly associated. online supplemental 
table S4 shows multivariable associations in a group free 
from the most serious diseases at TP2. Both age and male 
sex were associated with subsequent multimorbidity, 
with educational attainment, current cigarette smoking, 
plasma vitamin C, BMI >30 kg/m² and physical inactivity 
all predicting future multimorbidity. Systolic blood pres-
sure was attenuated while other factors including choles-
terol were more strongly associated than at baseline.
DISCUSSION
In this community- based population followed prospec-
tively, we observed incident hospital multimorbidity 
admission rates over 5- year and 10- year periods, which 
as expected were strongly related to increasing age. We 
also observed that those with multimorbid hospital admis-
sions had substantially more days in the hospital over the 
outcome periods. In multivariable analyses, the risk of 
such admissions is predicted by age, male sex and several 
potentially modifiable factors. Participants at baseline 
who smoked cigarettes, had BMI >30, were physically inac-
tive or had a diet low in fruit and vegetables all had higher 
likelihood of having subsequent hospital admissions with 
multimorbidity. Measurements made on a subset of the 
cohort 12 years after baseline who were followed up 
subsequently confirmed the baseline findings while also 
demonstrating an association for low education level in 
an older cohort with incident multimorbidity.
Strengths and limitations of the study
Most studies of multimorbidity focus on its consequences 
and those examining risk factors for multimorbidity are 
largely cross- sectional. While many prospective studies 
have examined the relationship between baseline char-
acteristics and specific incident diseases or mortality, 
establishing multimorbidity as an endpoint is more 
Figure 2 Rate of hospital admissions with multimorbidity, 
defined as Charlson Comorbidity Index ≥3, by age group and 
sex, over the 10- year follow- up period 1999–2009, excluding 
those with cardiovascular disease, cancer or diabetes at 
baseline.
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Table 2 Descriptive characteristics at baseline in 25 014 men and women aged 40–79 by 10- year Charlson Comorbidity Index 
(CCI), 1999–2009
Total No admissions CCI=0 CCI=1 CCI=2 CCI ≥3
Hospital duration 1999–2009, days
  Mean±SD 16.3±46.5 0.0±0.0 9.1±28.3 24.9±71.5 30.4±43.0 57.8±77.5
Total hospital admissions 1999–2009
  Mean±SD 3.8±16.2 0.0±0.0 2.8±3.1 4.5±6.0 6.4±8.3 13.4±43.9
Age, years
  Mean±SD 59.0±9.3 55.4±8.6 57.9±8.8 62.0±8.8 62.9±8.8 65.0±8.0
Body mass index, kg/m²
  Mean±SD 26.4±3.9 25.9±3.7 26.2±3.8 26.8±4.1 26.8±4.3 27.3±4.2
Cigarette smoking, n (%)
  Current 2904 751 (25.9) 1008 (34.7) 410 (14.1) 291 (10.0) 444 (15.3)
  Former 10 423 2558 (24.5) 4007 (38.4) 1352 (13.0) 979 (9.4) 1527 (14.7)
  Never 11 469 3476 (30.3) 4821 (42.0) 1245 (10.9) 903 (7.9) 1024 (8.9)
Social class dichotomised, n (%)
  Non- manual 14 717 4400 (29.9) 5707 (38.8) 1733 (11.8) 1256 (8.5) 1621 (11.0)
  Manual 9752 2304 (23.6) 4029 (41.3) 1214 (12.4) 886 (9.1) 1319 (13.5)
Level of education, n (%)
  Higher level 15 866 4922 (31.0) 6333 (39.9) 1724 (10.9) 1277 (8.0) 1610 (10.1)
  Lower level 9130 1910 (20.9) 3576 (39.2) 1310 (14.3) 916 (10.0) 1418 (15.5)
Simple physical activity index, n (%)
  Inactive 7559 1681 (22.2) 2666 (35.3) 1116 (14.8) 788 (10.4) 1308 (17.3)
  Moderately inactive 7187 2084 (29.0) 2904 (40.4) 819 (11.4) 610 (8.5) 770 (10.7)
  Moderately active 5688 1708 (30.0) 2353 (41.4) 608 (10.7) 470 (8.3) 549 (9.7)
  Active 4580 1362 (29.7) 1995 (43.6) 492 (10.7) 325 (7.1) 406 (8.9)
Alcohol intake, units per week
  Mean±SD 7.1±9.5 7.7±9.6 6.9±9.1 6.9±9.5 6.7±9.8 6.8±10.3
Plasma vitamin C, µmol/L
  Mean±SD 53.5±20.3 55.3±19.8 55.4±19.9 50.5±20.3 51.3±20.9 47.6±20.6
Systolic blood pressure, mm Hg
  Mean±SD 135.3±18.3 132.4±17.4 133.5±17.5 138.7±18.7 138.6±19.2 142.2±19.3
Total cholesterol, mmol/L
  Mean±SD 6.2±1.2 6.1±1.1 6.1±1.1 6.3±1.2 6.2±1.2 6.3±1.2
Prevalent heart attack, n (%)
  No reported heart attack 24 253 6745 (27.8) 9764 (40.3) 2886 (11.9) 2097 (8.6) 2761 (11.4)
  Self- reported heart attack 728 85 (11.7) 143 (19.6) 146 (20.1) 94 (12.9) 260 (35.7)
Prevalent stroke, n (%)
  No reported stroke 24 660 6786 (27.5) 9821 (39.8) 2975 (12.1) 2151 (8.7) 2927 (11.9)
  Self- reported stroke 329 45 (13.7) 87 (26.4) 57 (17.3) 41 (12.5) 99 (30.1)
Prevalent cancer, n (%)
  No reported cancer 23 688 6595 (27.8) 9449 (39.9) 2878 (12.1) 2031 (8.6) 2735 (11.5)
  Self- reported cancer 1301 237 (18.2) 459 (35.3) 155 (11.9) 162 (12.5) 288 (22.1)
Prevalent diabetes, n (%)
  No reported diabetes 24 442 6760 (27.7) 9844 (40.3) 2941 (12.0) 2111 (8.6) 2786 (11.4)
  Self- reported diabetes 541 71 (13.1) 61 (11.3) 90 (16.6) 81 (15.0) 238 (44.0)
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Table 3 Multivariable logistic regression of risk factors for 5- year and 10- year hospital admissions with multimorbidity in 25 
014 men and women
5- year multimorbidity*, 
1999–2004
OR (95% CI) P value
10- year multimorbidity*, 
1999–2009
OR (95% CI) P value
Model 1
  Male sex 1.49 (1.34 to 1.67) <0.001 1.56 (1.44 to 1.69) <0.001
  Age per 10 years 2.27 (2.13 to 2.44) <0.001 2.34 (2.23 to 2.46) <0.001
  Manual social class 1.20 (1.07 to 1.35) 0.002 1.22 (1.12 to 1.33) <0.001
  Lower education level 1.15 (1.02 to 1.30) 0.023 1.19 (1.09 to 1.30) <0.001
Model 2
  Male sex 1.39 (1.24 to 1.56) <0.001 1.47 (1.35 to 1.60) <0.001
  Age per 10 years 2.11 (1.97 to 2.26) <0.001 2.21 (2.10 to 2.32) <0.001
  Manual social class 1.22 (1.08 to 1.37) 0.001 1.23 (1.13 to 1.34) <0.001
  Lower education level 1.13 (1.00 to 1.28) 0.053 1.17 (1.07 to 1.28) <0.001
  Prevalent CVD 2.23 (1.85 to 2.68) <0.001 2.25 (1.93 to 2.60) <0.001
  Prevalent cancer 2.11 (1.75 to 2.54) <0.001 1.92 (1.65 to 2.22) <0.001
  Prevalent diabetes 4.41 (3.55 to 5.45) <0.001 4.32 (3.57 to 5.21) <0.001
Model 3
  Male sex 1.24 (1.07 to 1.42) 0.003 1.33 (1.20 to 1.47) <0.001
  Age per 10 years 2.16 (1.99 to 2.34) <0.001 2.29 (2.16 to 2.43) <0.001
  Manual social class 1.09 (0.95 to 1.25) 0.214 1.17 (1.06 to 1.29) 0.002
  Lower education level 1.06 (0.92 to 1.21) 0.447 1.08 (0.98 to 1.20) 0.112
  Current smoker 1.71 (1.42 to 2.05) <0.001 1.73 (1.51 to 1.98) <0.001
  BMI >30 kg/m² 1.32 (1.12 to 1.56) <0.001 1.45 (1.28 to 1.63) <0.001
  Alcohol intake, units per week 1.00 (0.99 to 1.01) 0.872 1.00 (1.00 to 1.01) 0.666
  Physically inactive 1.26 (1.10 to 1.44) <0.001 1.15 (1.04 to 1.26) 0.006
  Plasma vitamin C per SD 0.81 (0.75 to 0.86) <0.001 0.84 (0.80 to 0.88) <0.001
  Prevalent CVD 2.02 (1.63 to 2.49) <0.001 2.17 (1.84 to 2.57) <0.001
  Prevalent cancer 2.22 (1.79 to 2.72) <0.001 2.06 (1.74 to 2.43) <0.001
  Prevalent diabetes 3.53 (2.73 to 4.52) <0.001 3.54 (2.85 to 4.39) <0.001
Model 4
  Male sex 1.23 (1.07 to 1.43) 0.005 1.32 (1.19 to 1.47) <0.001
  Age per 10 years 2.08 (1.91 to 2.27) <0.001 2.19 (2.06 to 2.33) <0.001
  Manual social class 1.09 (0.95 to 1.25) 0.235 1.16 (1.05 to 1.28) 0.004
  Lower education level 1.06 (0.92 to 1.22) 0.420 1.09 (0.99 to 1.21) 0.091
  Current smoker 1.72 (1.43 to 2.07) <0.001 1.74 (1.52 to 2.00) <0.001
  BMI >30 kg/m² 1.31 (1.11 to 1.54) 0.001 1.40 (1.24 to 1.58) <0.001
  Alcohol intake, units per week 1.00 (0.99 to 1.01) 0.878 1.00 (1.00 to 1.01) 0.800
  Physically inactive 1.25 (1.09 to 1.43) 0.001 1.14 (1.04 to 1.26) 0.008
  Plasma vitamin C per SD 0.81 (0.76 to 0.87) <0.001 0.85 (0.81 to 0.89) <0.001
  Systolic blood pressure per SD 1.10 (1.03 to 1.17) 0.005 1.12 (1.07 to 1.18) <0.001
  Total cholesterol per SD 0.99 (0.92 to 1.05) 0.690 0.99 (0.94 to 1.04) 0.614
  Prevalent CVD 2.06 (1.66 to 2.54) <0.001 2.22 (1.87 to 2.62) <0.001
  Prevalent cancer 2.23 (1.80 to 2.75) <0.001 2.05 (1.73 to 2.42) <0.001
  Prevalent diabetes 3.42 (2.64 to 4.39) <0.001 3.41 (2.74 to 4.24) <0.001
*Charlson Comorbidity Index ≥3 vs Charlson Comorbidity Index ≤2 or no hospital admission.
BMI, body mass index; CVD, cardiovascular disease.
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challenging. By using the CCI to define multimorbidity, 
we were able to show that the chronic diseases defined 
by the index had considerably higher average length of 
stay than other conditions requiring hospitalisation and 
that length of stay increased with higher CCI score. The 
current population- based study in a defined commu-
nity was able to assess incident hospital admissions with 
multimorbidity to enable estimates of 5- year and 10- year 
rates by age and sex. We were also able to document the 
relationship between demographic, lifestyle and physio-
logical factors and subsequent hospitalisations for multi-
morbidity. The EPIC- Norfolk cohort has been followed 
for 20 years, enabling us to examine the determinants 
of multimorbidity at two time- points: in mainly middle- 
aged participants (40–79 years) and mainly old- aged 
participants (48–92 years) in a subcohort 12 years later 
after major organisational changes had been made to 
the National Health Service (NHS). We were also able to 
examine associations with and without excluding partici-
pants with known prevalent conditions at baseline.
While not attempting to examine clusters or pathways of 
chronic disease, we have identified risk factors that predict 
any hospital admissions with multimorbidity. It is possible 
that some factors we observed will be more strongly asso-
ciated with certain combinations of diseases and others 
less so. However, the burden of resources experienced 
by hospitals can best be mitigated by early public health 
advice, prior to the onset of disease if possible, which can 
only be general in nature. Our findings are in line with 
current public health advice such as smoking cessation, 
a diet containing fruit and vegetables and regular exer-
cise and, given the huge additional burden placed on the 
Table 4 Multivariable logistic regression of risk factors excluding participants with prevalent CVD, cancer or diabetes for 5- 
year and 10- year hospital admissions with multimorbidity in 22 278 men and women
5- year multimorbidity*, 
1999–2004
OR (95% CI) P value
10- year multimorbidity*, 
1999–2009
OR (95% CI) P value
Model 1
  Male sex 1.47 (1.29 to 1.68) <0.001 1.52 (1.38 to 1.67) <0.001
  Age per 10 years 2.19 (2.02 to 2.37) <0.001 2.31 (2.19 to 2.45) <0.001
  Manual social class 1.23 (1.07 to 1.42) 0.003 1.22 (1.11 to 1.34) <0.001
  Lower education level 1.20 (1.04 to 1.39) 0.011 1.16 (1.05 to 1.28) 0.003
Model 2
  Male sex 1.32 (1.13 to 1.55) <0.001 1.39 (1.24 to 1.55) <0.001
  Age per 10 years 2.24 (2.05 to 2.46) <0.001 2.40 (2.25 to 2.56) <0.001
  Manual social class 1.13 (0.96 to 1.32) 0.131 1.17 (1.05 to 1.30) 0.006
  Lower education level 1.07 (0.91 to 1.25) 0.416 1.05 (0.93 to 1.17) 0.428
  Current smoker 1.85 (1.50 to 2.26) <0.001 1.84 (1.58 to 2.13) <0.001
  BMI >30 kg/m² 1.31 (1.07 to 1.58) 0.006 1.53 (1.34 to 1.75) <0.001
  Alcohol intake, units per week 1.00 (0.99 to 1.01) 0.789 1.00 (1.00 to 1.01) 0.805
  Physically inactive 1.25 (1.07 to 1.46) 0.004 1.17 (1.05 to 1.31) 0.005
  Plasma vitamin C per SD 0.82 (0.76 to 0.89) <0.001 0.85 (0.80 to 0.90) <0.001
Model 3
  Male sex 1.32 (1.12 to 1.56) 0.001 1.37 (1.22 to 1.54) <0.001
  Age per 10 years 2.15 (1.95 to 2.37) <0.001 2.30 (2.15 to 2.46) <0.001
  Manual social class 1.11 (0.95 to 1.31) 0.178 1.15 (1.03 to 1.29) 0.012
  Lower education level 1.07 (0.91 to 1.26) 0.383 1.05 (0.94 to 1.18) 0.393
  Current smoker 1.88 (1.52 to 2.30) <0.001 1.86 (1.60 to 2.15) <0.001
  BMI >30 kg/m² 1.30 (1.07 to 1.58) 0.007 1.48 (1.30 to 1.70) <0.001
  Alcohol intake, units per week 1.00 (0.99 to 1.01) 0.828 1.00 (0.99 to 1.01) 0.941
  Physically inactive 1.24 (1.06 to 1.45) 0.007 1.16 (1.04 to 1.29) 0.009
  Plasma vitamin C per SD 0.83 (0.77 to 0.90) <0.001 0.86 (0.81 to 0.91) <0.001
  Systolic blood pressure per SD 1.12 (1.03 to 1.21) 0.005 1.13 (1.07 to 1.19) <0.001
  Total cholesterol per SD 0.98 (0.91 to 1.06) 0.607 0.97 (0.92 to 1.03) 0.328
*Charlson Comorbidity Index ≥3 versus Charlson Comorbidity Index ≤2 or no hospital admission.
BMI, body mass index; CVD, cardiovascular disease.
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NHS by multimorbidity, should further emphasise the 
need for public health advice and intervention.
Multimorbidity can be defined in a number of ways, 
such as disease counts or using various indexes.39 By 
restricting the definition to a relatively small subset of 
chronic conditions such as in the CCI, inevitably some 
conditions will not be counted. It is notable that the CCI 
does not include depression or mental health, asthma 
or respiratory diseases, epilepsy, hypothyroidism, muscu-
loskeletal problems or atrial fibrillation, all common 
in a primary care setting.40 In addition to the CCI and 
other commonly used systems,41 authors have used many 
other definitions with variable numbers of underlying 
conditions and hence the prevalence of multimorbidity 
varies widely. However, CCI is a widely used measure of 
multimorbidity.
Since the CCI is weighted to predict mortality, it may 
be better able to assess health service burden than a 
simple disease count, since procedures required for 
higher weighted conditions will generally be more costly. 
However, it may be less effective as an indicator of multiple 
long- term conditions. Some chronic conditions such as 
musculoskeletal and mental health diseases not included 
in the CCI are nevertheless likely to require long- stay 
inpatient care. However, increasing CCI had longer 
hospital length of stay in the present study and this has 
also been reported in several other studies.42 43 Medical 
conditions such as obesity have well- established links 
to many diseases but, as non- diseases, are not included 
in the CCI. The use of CCI ≥3 to define multimorbidity 
classifies a small number of participants with one serious 
disease with a high CCI weight as multimorbid. However, 
a sensitivity excluding these people gave virtually identical 
results. Studies examining the longitudinal predictors 
of future multimorbidity generally rely on self- reported 
disease, but our study used the CCI from linked hospital 
medical coding.
When examining the relationship between lifestyle 
factors and health outcomes, confounding will always be 
a limitation. Individuals who smoke, are less physically 
active and eat a poor diet for example are likely to differ 
from those with a contrasting lifestyle with respect to 
other factors relating to the likelihood of future multi-
morbidity, including their age, sex, lifestyle factors exam-
ined in this study and others unknown. However, the 
associations we report were consistent after multivariable 
adjustment for other factors. Differential mortality is 
another possible limitation and would occur for any of 
the factors examined if participants with an apparently 
unhealthy characteristic were more likely to have died 
earlier than those with the contrary healthy characteristic 
and hence were less likely to use hospital services for the 
full follow- up period. However, the results for the 5- year 
follow- up period where very few deaths occurred were 
consistent with the longer 10- year follow- up period. While 
it is possible that some participants were multimorbid at 
baseline, we examined those with and without baseline 
self- reported major chronic disease.
Comparison with other studies
Estimates of the prevalence of multimorbidity vary 
widely, partly due to the variety of definitions, number of 
diseases, weighting and so on used in studies, but range 
from 55% to 98% in the elderly.6 Most studies report 
multimorbidity associated with age and present in more 
than half of those aged 65 and older.3 44 Age was strongly 
associated with future hospitalisation and incident multi-
morbidity in our study and has been reported to increase 
hospitalised multimorbidity in elderly patients.45 Many 
studies have found that women have a higher rate of 
multimorbidity than men,6 44 46–48 but we observed the 
converse, with male sex strongly predicting future multi-
morbidity. The use of CCI in the context of prospective 
hospital admissions rather than cross- sectional multimor-
bidity in a primary care setting may explain the higher 
proportion of multimorbid men. Physical- mental comor-
bidity is reported higher among women in primary care,49 
and mental health, which is not included in the CCI, may 
be more likely to be treated in a primary care than in an 
acute hospital setting.
Despite the considerable literature relating to multi-
morbidity, very few studies have examined the modifi-
able determinants of incident multimorbidity. Incident 
cancer and cardiometabolic multimorbidity were exam-
ined in a recent multicentre study which included data 
from the present study21; prediagnostic healthy lifestyle 
behaviours were reported to be inversely associated with 
the risk. BMI was also reported to be associated with 
incident cardiometabolic multimorbidity in a pooled 
analysis of 16 cohort studies.22 A Finnish study examined 
incident multimorbidity in both disease- free and those 
with baseline diabetes and CVD.24 They reported some 
similar findings to the present study such as associations 
with cigarette smoking, physical inactivity and BMI, but 
associations for low education level and systolic blood 
pressure were only found in men. Multimorbidity was 
defined using five common diseases, and time- to- event 
10- year follow- up was used rather than a follow- up period 
approach in this study. Participants in the Finnish cohort 
were younger than those in EPIC- Norfolk, with the 
oldest participant 74 years at the end of follow- up against 
90 years in the EPIC- Norfolk baseline and 100 years at 
TP2. Studies using data from an English longitudinal 
cohort and using self- reported disease counts to define 
multimorbidity reported associations in physical activity, 
obesity and low level of wealth and an increased risk 
of multimorbidity when combined with other lifestyle 
factors such smoking, obesity and inadequate fruit and 
vegetable consumption.25 26 However, they found no asso-
ciation with educational attainment or excess alcohol 
consumption. Education, which was associated in older 
participants at TP2 in our study, has been linked to multi-
morbidity in cross- sectional studies50 and prospectively.24 
Socioeconomic status was reported to predict the devel-
opment of multimorbidity throughout the life course in 
a Scottish longitudinal study.51 Both educational attain-
ment and occupational social class were attenuated in 
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our study possibly due to the models including plasma 
vitamin C, also a marker of socioeconomic status. While 
smoking was a strong predictor, we did not find an associ-
ation with alcohol drinking. However, other studies in the 
literature are inconsistent, with some finding no associa-
tion with cigarette smoking and alcohol consumption in 
cross- sectional analyses.1
Generalisability
While hospital admissions with multimorbidity provide an 
objective indicator of both health service and individual 
burden of the condition, studies of hospital admissions in 
many countries are limited by factors relating to differen-
tial accessibility to healthcare such as health insurance, 
income and healthcare policy. Although not entirely free 
of differential accessibility, the NHS in the UK, with service 
free at the point of delivery for all residents, provides an 
opportunity to examine hospitalised multimorbidity with 
fewer of these constraints. Healthcare policy and criteria 
for admission change over time, not least in the UK over 
the 20- year period of this study, so we examined admis-
sions and risk factors for multimorbidity over two inde-
pendent time periods using new repeated measures and 
found consistent results.
CONCLUSIONS AND POLICY IMPLICATIONS
We observed in a long- term population- based study that 
age, male sex and potentially modifiable factors including 
smoking, BMI, physical inactivity and a diet low in fruit 
and vegetables predict future incident hospitalised multi-
morbidity. Multimorbidity is increasingly common among 
elderly hospital inpatients due in part to improved effi-
cacy of treatments and drugs. While considerable effort 
is being focused on the progression, disease clustering 
and treatment of patients with multimorbidity, there has 
been less attention on the long- term predictors of future 
incident multimorbidity. This study suggests that modest 
difference in lifestyle may have the potential to mitigate 
the future burden of multimorbidity in the population.
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